With a primary goal of simplifying the delivery of solution-stable or lyophilized-parenteral medications, Valeritas, LLC currently offers four unique, proprietary products designed to improve patient compliance with therapy regimens.

h-Patch™ Single-use, Disposable Basal Bolus System
The recently introduced h-Patch bolus system provides Type 2 diabetes patients with an easy-to-use, unobtrusive way to manage their daily insulin requirements. The h-Patch system addresses the needs of older diabetes suffers, among other patient populations, for whom conventional methods of insulin delivery are too cumbersome or complicated to assure compliance. The h-Patch is easily applied, its micro-needle assures minimal pain, and it can be safely and easily disposed of.

e-Patch™ Control Release Disposable Micro Pump System
The e-Patch pump system is a discrete micro-infusion system designed to deliver drugs continuously into subcutaneous tissue. The system combines the user advantages of transdermal patches with the accuracy and flexibility of conventional ambulatory pumps. The e-Patch pump system provides improved patient compliance and flexible delivery profiles over an extremely wide range of therapeutic applications.

Micro-Trans™ Microneedle Transdermal Delivery System
The Micro-Trans delivery system uses a patented array of either hollow metal or solid PLGA micro-needles enabling drug delivery or ISF sampling in the dermis without limitations of molecular weight or skin characteristics. Shallow skin penetration avoids contact with pain receptors, making the system comfortable and convenient for patients to use.

Mini-Ject™ Pre-Filled Needle-Free Delivery System
The Mini-Ject platform is the next generation of needle-free injection systems. It combines features of accuracy and reliability with a variety of pre-filled options, comfortable administration, and full disposability. All this in a design that's easy for patients to use.

All of Valeritas' drug delivery systems share a primary objective: to enhance the ease-of-use, compliance and delivery profile for injectable medications. Validated in numerous clinical studies, each of Valeritas' four product platforms reduces the pain, cost and inconvenience involved in administering injectable drugs to manage chronic diseases.

By creating delivery platforms that offer key benefits such as ease-of-use, tailored rate delivery profiles, single-use and pre-filled delivery configurations, Valeritas' products enhance currently marketed injectable medications and are well positioned to enable greater potential for medications yet to come.